(Q44526053)

3 December 2017

title

Enhancement of HIV-specific cytotoxic T lymphocyte responses by zidovudine (AZT) treatment (English)

1 reference

https://api.crossref.org/works/10.1111/J.1365-2249.1992.TB06405.X

11 November 2022

0 references

1 reference

1 reference

https://api.crossref.org/works/10.1111/J.1365-2249.1992.TB06405.X

11 November 2022

2

F. Michel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1733639

11 November 2022

author name string

Langlade-Demoyen P

3

1 reference

3 December 2017

G. Dadaglio

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1733639

11 November 2022

P. Langlade-Demoyen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1733639

11 November 2022

P. Sansonetti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1733639

11 November 2022

D. Chevrier

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1733639

11 November 2022

F. Vuillier

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1733639

11 November 2022

F. Plata

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1733639

11 November 2022

A. Hoffenbach

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1733639

11 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1733639

11 November 2022

publication date

1 January 1992

1 reference

full work available at URL

3 December 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2249.1992.tb06405.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2249.1992.TB06405.X

https://academic.oup.com/cei/article-pdf/87/1/7/42213362/j.1365-2249.1992.tb06405.x.pdf

11 November 2022

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1111/J.1365-2249.1992.TB06405.X

Clinical and Experimental Immunology

11 November 2022

published in

1 reference

3 December 2017

volume

87

1 reference

3 December 2017

issue

1

1 reference

3 December 2017

page(s)

7-14

1 reference

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1992.TB06405.X

Clinical pharmacology of 3'-azido-2',3'-dideoxythymidine (zidovudine) and related dideoxynucleosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1992.TB06405.X

The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1992.TB06405.X

Human immunodeficiency virus (HIV) antigenemia (p24) in the acquired immunodeficiency syndrome (AIDS) and the effect of treatment with zidovudine (AZT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1992.TB06405.X

Toxicity of 3'-azido-3'-deoxythymidine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for normal human hematopoietic progenitor cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1992.TB06405.X

Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals: distinct types of effector cells mediate killing of targets expressing gag and env proteins

21 January 2018

1 reference

12 December 2020

Increased T-cell colony formation in AIDS patients treated with zidovudine: a possible mechanism for increased lymphocyte number

1 reference

12 December 2020

Cell-mediated suppression of HIV-specific cytotoxic T lymphocytes

1 reference

12 December 2020

HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy

1 reference

12 December 2020

Human allospecific cytolytic T lymphocyte lysis of a murine cell transfected with HLA-A2

1 reference

12 December 2020

HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides

1 reference

12 December 2020

Defective in vitro growth of the hemopoietic progenitor cells in the acquired immunodeficiency syndrome

1 reference

12 December 2020

AIDS virus-specific cytotoxic T lymphocytes in lung disorders

1 reference

12 December 2020

HIV-specific cytotoxic T lymphocytes in seropositive individuals

1 reference

12 December 2020

Amplification of HTLV-III/LAV infection by antigen-induced activation of T cells and direct suppression by virus of lymphocyte blastogenic responses

1 reference

12 December 2020

Azidothymidine associated with bone marrow failure in the acquired immunodeficiency syndrome (AIDS)

1 reference

12 December 2020

Significant changes in HIV antigen level in the serum of patients treated with azidothymidine.

1 reference

12 December 2020

Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS

1 reference

12 December 2020

Hematologic abnormalities in the acquired immune deficiency syndrome

1 reference

12 December 2020

Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis.

1 reference

12 December 2020

Group-specific, major histocompatibility complex class I-restricted cytotoxic responses to human immunodeficiency virus 1 (HIV-1) envelope proteins by cloned peripheral blood T cells from an HIV-1-infected individual

1 reference

12 December 2020

Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans

1 reference

12 December 2020

Immune recognition of AIDS virus antigens by human and murine cytotoxic T lymphocytes

1 reference

12 December 2020

HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals

1 reference

12 December 2020

Suppression of in vitro haematopoiesis following human immunodeficiency virus infection

1 reference

12 December 2020

3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro

1 reference

12 December 2020

Recognition of HIV glycoprotein gp120 by T cells. Role of monocyte CD4 in the presentation of gp120

1 reference

12 December 2020

Multiple subsets of HIV-specific cytotoxic T lymphocytes in humans and in mice

1 reference

12 December 2020

A lectin-binding soluble factor released by CD8+CD57+ lymphocytes from AIDS patients inhibits T cell cytotoxicity

1 reference

12 December 2020

Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase

1 reference

12 December 2020

Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex

1 reference

12 December 2020

Response of human-immunodeficiency-virus-associated neurological disease to 3'-azido-3'-deoxythymidine

1 reference

12 December 2020

T cells can present antigens such as HIV gp120 targeted to their own surface molecules

1 reference

12 December 2020

Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides

1 reference

12 December 2020

Phenotypic heterogeneity of cerebrospinal fluid-derived HIV-specific and HLA-restricted cytotoxic T-cell clones

1 reference

12 December 2020

HTLV-III large envelope protein (gp120) suppresses PHA-induced lymphocyte blastogenesis.

1 reference

12 December 2020

Analysis of host-virus interactions in AIDS with anti-gp120 T cell clones: effect of HIV sequence variation and a mechanism for CD4+ cell depletion

1 reference

12 December 2020

T-cell-mediated suppression of hematopoiesis

1 reference

12 December 2020

An antigenic peptide of the HIV-1 NEF protein recognized by cytotoxic T lymphocytes of seropositive individuals in association with different HLA-B molecules

1 reference

12 December 2020

Identifiers

1 reference

National Center for Biotechnology Information

3 December 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1733639

11 November 2022

1 reference